The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.

Existing backer Google has reinvested in the mobile operating system developer to increase its overall funding to $79m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The T-Cell therapy developer has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.

GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer.

Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.

The Orange-backed electronics financing provider has increased its total equity and debt financing to $70m with a Greylock-led series B round.

MassMutual Ventures co-led the healthcare data platform developer's series B round, which also featured Aviva Ventures and Jianke.

GLP and China International Marine Containers-backed Yidaichu has allocated the $17.4m it raised to hiring staff, further developing its technology and improving its core offering.

Susquehanna International Group has led a series B round for elderly healthcare services provider Shanzhen that was in the eight-figure dollar range.